title: Frusemide-induced nephrocalcinosis in very low birth weight infants.
abstract: Three very low birth weight infants, treated with frusemide for broncho-pulmonary dysplasia are described. They all developed medullary nephrocalcinosis identifiable by real time ultrasound. The sonographic findings of diffuse medullary hyper-echogenicity appears to be specific for nephrocalcinosis.
authors.affiliation: Royal Alexandra Hospital for Sick Children, Brighton, England.
authors.forename: I J
authors.initials: IJ
authors.lastname: Kenney
authors.forename: C G
authors.initials: CG
authors.lastname: Aiken
authors.forename: W
authors.initials: W
authors.lastname: Lenney
mesh_terms: D001997:Bronchopulmonary Dysplasia / Q000188:drug therapy; D005260:Female; D005665:Furosemide / Q000009:adverse effects*; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008297:Male; D009397:Nephrocalcinosis / Q000139:chemically induced* / Q000175:diagnosis; D014463:Ultrasonography
chemical_list: D005665:Furosemide